Engineers Gate Manager LP Aeglea Bio Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.87 - $4.77 $28,050 - $71,550	-15,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.5 - $8.42 $52,500 - $126,300	15,000 New	15,000 $71,000
Q2 2021 Aug 16, 2021	SELL	$6.32 - $8.38 $68,256 - $90,504	-10,800 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.76 - $8.57 $73,008 - $92,556	10,800 New	10,800 $86,000
Q4 2020 Feb 16, 2021	SELL	$7.02 - $9.83 $101,088 - $141,552	-14,400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$6.51 - $9.33 $93,744 - $134,352	14,400 New	14,400 $102,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.